Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Terauchi

Showing results (1-10 of 389) with videos related to

Pageof 39
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 28, 2007
[PPARgamma and metabolic syndrome]Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Insulin receptor substrate (IRS)]Yasuo Terauchi
Journal of Diabetes Investigation|November 21, 2014
Selective and sequential loss of transcriptional factors: A hallmark of β-cell failure in type 2 diabetes?Jun Shirakawa, Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 3, 2002
[Knockout mouse models for type 2 diabetes. Mice with insulin resistance]Yasuo Terauchi, Takashi Kadowaki
Endocrine Journal|August 31, 2002
Insights into molecular pathogenesis of type 2 diabetes from knockout mouse modelsYasuo Terauchi, Takashi Kadowaki
Endocrine Journal|November 8, 2019
Newer perspective on the coupling between glucose-mediated signaling and β-cell functionalityJun Shirakawa, Yasuo Terauchi
Journal of Diabetes Investigation|November 28, 2019
Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancerJun Shirakawa, Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Impaired glucose tolerance (IGT): current understanding and future research directions]Yasuo Terauchi, Takashi Kadowaki
Vitamins and Hormones|July 22, 2018
Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and ObesityKazutaka Aoki, Yasuo Terauchi
Expert Opinion on Pharmacotherapy|August 28, 2019
The efficacy and safety of luseogliflozin and sitagliptin depending on the sequence of administration in patients with type 2 diabetes mellitus: a randomized controlled pilot studyMasahiro Takihata, Yasuo Terauchi
Pageof 39

Showing results (1-10 of 389) with videos related to

Sort By:
Pageof 39
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 28, 2007
[PPARgamma and metabolic syndrome]Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Insulin receptor substrate (IRS)]Yasuo Terauchi
Journal of Diabetes Investigation|November 21, 2014
Selective and sequential loss of transcriptional factors: A hallmark of β-cell failure in type 2 diabetes?Jun Shirakawa, Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 3, 2002
[Knockout mouse models for type 2 diabetes. Mice with insulin resistance]Yasuo Terauchi, Takashi Kadowaki
Endocrine Journal|August 31, 2002
Insights into molecular pathogenesis of type 2 diabetes from knockout mouse modelsYasuo Terauchi, Takashi Kadowaki
Endocrine Journal|November 8, 2019
Newer perspective on the coupling between glucose-mediated signaling and β-cell functionalityJun Shirakawa, Yasuo Terauchi
Journal of Diabetes Investigation|November 28, 2019
Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancerJun Shirakawa, Yasuo Terauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Impaired glucose tolerance (IGT): current understanding and future research directions]Yasuo Terauchi, Takashi Kadowaki
Vitamins and Hormones|July 22, 2018
Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and ObesityKazutaka Aoki, Yasuo Terauchi
Expert Opinion on Pharmacotherapy|August 28, 2019
The efficacy and safety of luseogliflozin and sitagliptin depending on the sequence of administration in patients with type 2 diabetes mellitus: a randomized controlled pilot studyMasahiro Takihata, Yasuo Terauchi
Pageof 39